{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:56:07Z","timestamp":1785912967353,"version":"3.56.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1127390"],"award-info":[{"award-number":["APP1127390"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In Australia, tobacco smoking rates have declined but inequalities remain with significantly higher smoking prevalence among low-socioeconomic populations. Clinical trial data suggest vaporized nicotine products (VNPs) aid smoking cessation. Most VNP trials have used refillable tank systems, but newer generation (pod) devices now comprise the largest market share yet have limited clinical trial evidence on safety and effectiveness. This study evaluates the effectiveness, safety and cost-effectiveness of VNPs (pod and tank device) compared with nicotine replacement therapy ([NRT]\u2014gum or lozenge) for smoking cessation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a two-arm, open-label, superiority, parallel group, randomized controlled trial (RCT) with allocation concealment and blinded outcome assessment. The RCT is conducted at the National Drug and Alcohol Research Centre at the University of New South Wales, Sydney, Australia. Participants are people who smoke daily, are interested in quitting and receive a government pension or allowance (<jats:italic>N<\/jats:italic> = 1058). Participants will be randomized (1:1 ratio) to receive 8 weeks of free: VNPs, with pod (40 mg\/mL nicotine salt) and tank device (18 mg\/mL freebase nicotine) in mixed flavours; or NRT (gum or lozenge; 4 mg). All participants will receive daily text message behavioural support for 5 weeks. Assessments will be undertaken by telephone at baseline, with three follow-up calls (two check-in calls within the first month and final follow-up at 7 months post randomization) to ascertain smoking status, treatment adherence and adverse events. The primary outcome is 6-month continuous abstinence verified by carbon monoxide breath test of \u22645ppm at 7-month follow-up. Safety and cost-effectiveness of VNPs versus NRT will also be evaluated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Further data are required to strengthen certainty of evidence for VNPs aiding smoking cessation, particularly for newer generation pod devices. To our knowledge, this trial is the first to offer choice of VNPs and no comparative effectiveness trial data exists for new pod devices. If effective, the findings can inform wider implementation of VNPs to aid smoking cessation in a priority group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Australian New Zealand Clinical Trials Registry ACTRN12621000076875. Registered on 29 January 2021.\u00a0<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.anzctr.org.au\">https:\/\/www.anzctr.org.au<\/jats:ext-link><\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-022-06644-8","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T19:03:43Z","timestamp":1663182223000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0080-4853","authenticated-orcid":false,"given":"Bridget C","family":"Howard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayden","family":"McRobbie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Mendelsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Borland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Naughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Tutka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Zwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica C","family":"Boland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Aiken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Shakeshaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coral","family":"Gartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn L","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P","family":"Mattick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan J","family":"Courtney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"6644_CR1","unstructured":"Australian Bureau of Statistics. Pandemic insights into Australian smokers, 2020-2021. https:\/\/www.abs.gov.au\/articles\/pandemic-insights-australian-smokers-2020-21. Accessed 4 Apr 2022."},{"key":"6644_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.drugalcdep.2014.07.019","volume":"143","author":"SC Hitchman","year":"2014","unstructured":"Hitchman SC, Fong GT, Zanna MP, Thrasher JF, Chung-Hall J, Siahpush M. Socioeconomic status and smokers\u2019 number of smoking friends: findings from the International Tobacco Control (ITC) Four Country Survey. Drug Alcohol Depend. 2014;143:158\u201366.","journal-title":"Drug Alcohol Depend."},{"key":"6644_CR3","unstructured":"Australian Government, Australian Institute of Health and Welfare. National Drug Strategy Household Survey (NDSHS) 2019. https:\/\/www.aihw.gov.au\/about-our-data\/our-data-collections\/national-drug-strategy-household-survey\/2019-ndshs. Accessed 4 Apr 2022."},{"key":"6644_CR4","unstructured":"Australian Government Department of Health and Aged Care. Smoking and disadvantage evidence brief. https:\/\/www1.health.gov.au\/internet\/publications\/publishing.nsf\/Content\/smoking-disadvantage-evidence-brief~factors-smoking-levels. Accessed 29 Mar 2022."},{"key":"6644_CR5","volume-title":"Understanding hard to maintain behaviour change: a dual process approach","author":"R Borland","year":"2014","unstructured":"Borland R. Understanding hard to maintain behaviour change: a dual process approach. West Sussex, UK: Wiley-Blackwell; 2014."},{"issue":"6","key":"6644_CR6","doi-asserted-by":"publisher","first-page":"6403","DOI":"10.3390\/ijerph120606403","volume":"12","author":"RJ Courtney","year":"2015","unstructured":"Courtney RJ, Naicker S, Shakeshaft A, Clare P, Martire KA, Mattick RP. Smoking cessation among low-socioeconomic status and disadvantaged population groups: a systematic review of research output. Int J Environ Res Public Health. 2015;12(6):6403\u201322.","journal-title":"Int J Environ Res Public Health."},{"key":"6644_CR7","unstructured":"Kock L, West R, Beard E, Kale D, Brown J. Smoking in England - trends in electronic cigarette use in England. https:\/\/smokinginengland.info\/graphs\/e-cigarettes-latest-trends. Accessed 29 Mar 2022."},{"issue":"2","key":"6644_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00213-013-3249-8","volume":"231","author":"LOC Dawkins","year":"2014","unstructured":"Dawkins LOC. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacol. 2014;231(2):401\u20137.","journal-title":"Psychopharmacol."},{"key":"6644_CR9","unstructured":"Public Health England. E-cigarettes: An evidence update. https:\/\/www.gov.uk\/government\/publications\/e-cigarettes-an-evidence-update. Accessed 29 Mar 2022."},{"issue":"2","key":"6644_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1136\/tc.2009.031567","volume":"19","author":"C Bullen","year":"2010","unstructured":"Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugeson M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial. Tob Control. 2010;19(2):98\u2013103.","journal-title":"Tob Control."},{"issue":"9905","key":"6644_CR11","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/S0140-6736(13)61842-5","volume":"382","author":"C Bullen","year":"2013","unstructured":"Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet. 2013;382(9905):1629\u201337.","journal-title":"Lancet."},{"key":"6644_CR12","doi-asserted-by":"crossref","unstructured":"Wagener T L, Floyd EL, I. S, LM. D, Frank SG, Meier E, et al. Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users. Tob Control. 2017;26(e1):e23-e8.","DOI":"10.1136\/tobaccocontrol-2016-053041"},{"issue":"3","key":"6644_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/add.13183","volume":"111","author":"G St Helen","year":"2016","unstructured":"St Helen G, Havel C, Dempsey DA, Jacob P, Benowitz NL. Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes. Addiction. 2016;111(3):535\u201344.","journal-title":"Addiction"},{"issue":"11","key":"6644_CR14","doi-asserted-by":"publisher","first-page":"11220","DOI":"10.3390\/ijerph111111220","volume":"11","author":"K Adriaens","year":"2014","unstructured":"Adriaens K, Van Gucht D, Declerck P, Baeyens F. Effectiveness of the electronic cigarette: an eight-week Flemish study with six-month follow-up on smoking reduction, craving and experienced benefits and complaints. Int J Environ Res Public Health. 2014;11(11):11220\u201348.","journal-title":"Int J Environ Res Public Health."},{"issue":"11","key":"6644_CR15","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1007\/s11606-014-2889-7","volume":"29","author":"MB Steinberg","year":"2014","unstructured":"Steinberg MB, Zimmerman MH, Delnevo CD, Lewis MJ, Shukla P, Coups EJ, et al. E-cigarette versus nicotine inhaler: comparing the perceptions and experiences of inhaled nicotine devices. J Gen Intern Med. 2014;29(11):1444\u201350.","journal-title":"J Gen Intern Med."},{"issue":"6","key":"6644_CR16","doi-asserted-by":"publisher","first-page":"e66317","DOI":"10.1371\/journal.pone.0066317","volume":"8","author":"P Caponnetto","year":"2014","unstructured":"Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLOS One. 2014;8(6):e66317.","journal-title":"PLOS One."},{"key":"6644_CR17","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1038\/srep04133","volume":"4","author":"KE Farsalinos","year":"2014","unstructured":"Farsalinos KE, Spyrou A, Tsimopoulou K, Stefopoulos C, Romagna G, Voudris V. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices. Sci Rep. 2014;4:4133.","journal-title":"Sci Rep."},{"issue":"6","key":"6644_CR18","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/add.14936","volume":"115","author":"P Hajek","year":"2020","unstructured":"Hajek P, Pittaccio K, Pesola F, Myers Smith K, Phillips-Waller A, Przulj D. Nicotine delivery and users\u2019 reactions to Juul compared with cigarettes and other e-cigarette products. Addiction. 2020;115(6):1141\u20138.","journal-title":"Addiction."},{"issue":"5","key":"6644_CR19","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1007\/s00213-016-4512-6","volume":"234","author":"P Hajek","year":"2017","unstructured":"Hajek P, Przulj D, Phillips A, Anderson R, McRobbie H. Nicotine delivery to users from cigarettes and from different types of e-cigarettes. Psychopharmacology. 2017;234(5):773\u20139.","journal-title":"Psychopharmacology."},{"issue":"4","key":"6644_CR20","first-page":"CD010216","volume":"4","author":"J Hartmann-Boyce","year":"2021","unstructured":"Hartmann-Boyce J, McRobbie H, Lindson N, Bullen C, Begh R, Theodoulou A, et al. Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2021;4(4):CD010216.","journal-title":"Cochrane Database Syst Rev."},{"issue":"10","key":"6644_CR21","first-page":"CD006611","volume":"10","author":"R Whittaker","year":"2019","unstructured":"Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y, Dobson R. Mobile phone text messaging and app-based interventions for smoking cessation. Cochrane Database Syst Rev. 2019;10(10):CD006611.","journal-title":"Cochrane Database Syst Rev."},{"key":"6644_CR22","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin J, et al. SPIRIT 2013 Explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ."},{"issue":"1","key":"6644_CR23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.2021.7621","volume":"326","author":"RJ Courtney","year":"2021","unstructured":"Courtney RJ, McRobbie H, Tutka P, Weaver NA, Petrie D, Mendelsohn CP, et al. Effect of cytisine vs varenicline on smoking cessation: a randomized clinical trial. JAMA. 2021;326(1):56\u201364.","journal-title":"JAMA."},{"issue":"3","key":"6644_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/ntr\/ntw391","volume":"20","author":"VC Boland","year":"2018","unstructured":"Boland VC, Stockings EA, Mattick RP, McRobbie H, Brown J, Courtney R. The methodological quality and effectiveness of technology-based smoking cessation interventions for disadvantaged groups: a systematic review and meta-analysis. Nic Tob Res. 2018;20(3):276\u201385.","journal-title":"Nic Tob Res."},{"key":"6644_CR25","volume-title":"Be He@lthy Be Mobile: A handbook on how to implement mTobaccoCessation","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Be He@lthy Be Mobile: A handbook on how to implement mTobaccoCessation. Geneva: World Health Organization; 2015."},{"issue":"1\u20132","key":"6644_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00213-004-1923-6","volume":"177","author":"R West","year":"2004","unstructured":"West R, Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology (Berl). 2004;177(1\u20132):195\u20139.","journal-title":"Psychopharmacology (Berl)."},{"key":"6644_CR27","doi-asserted-by":"crossref","unstructured":"Gwaltney CJ, Metrik J, Kahler CW, Shiffman Saul. Self-efficacy and smoking cessation: a meta-analysis. Psychol Addict Behav. 2009;23(1):56-66.","DOI":"10.1037\/a0013529"},{"issue":"7","key":"6644_CR28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/ajad.12272","volume":"24","author":"P Dupont","year":"2015","unstructured":"Dupont P, Tack V, Blecha L, Reynaud M, Benyamina A, Amirouche A, et al. Smoker\u2019s identity scale: measuring identity in tobacco dependence and its relationship with confidence in quitting. Am J Addict. 2015;24(7):607\u201312.","journal-title":"Am J Addict."},{"issue":"2","key":"6644_CR29","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.drugalcdep.2013.09.001","volume":"133","author":"I Tombor","year":"2013","unstructured":"Tombor I, Shahab L, Brown J, West R. Positive smoker identity as a barrier to quitting smoking: findings from a national survey of smokers in England. Drug Alcohol Depend. 2013;133(2):740\u20135.","journal-title":"Drug Alcohol Depend."},{"issue":"7","key":"6644_CR30","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.addbeh.2006.10.008","volume":"32","author":"ML Steinberg","year":"2007","unstructured":"Steinberg ML, Krejci JA, Collett K, Brandon TH, Ziedonis DM, Chen K. Relationship between self-reported task persistence and history of quitting smoking, plans for quitting smoking, and current smoking status in adolescents. Addict Behav. 2007;32(7):1451\u201360.","journal-title":"Addict Behav."},{"issue":"2","key":"6644_CR31","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1136\/tc.2006.016279","volume":"16","author":"M Siahpush","year":"2007","unstructured":"Siahpush M, Borland R, Yong HH. Sociodemographic and psychosocial correlates of smoking-induced deprivation and its effect on quitting: findings from the International Tobacco Control Policy Evaluation Survey. Tob Control. 2007;16(2):e2.","journal-title":"Tob Control."},{"issue":"1","key":"6644_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1360-0443.2005.01292.x","volume":"101","author":"M Siahpush","year":"2006","unstructured":"Siahpush M, Carlin JB. Financial stress, smoking cessation and relapse: results from a prospective study of an Australian national sample. Addiction. 2006;101(1):121\u20137.","journal-title":"Addiction."},{"issue":"16","key":"6644_CR33","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","volume":"158","author":"K Bush","year":"1998","unstructured":"Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med. 1998;158(16):1789\u201395.","journal-title":"Arch Intern Med."},{"issue":"6","key":"6644_CR34","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1017\/S0033291702006074","volume":"32","author":"RC Kessler","year":"2002","unstructured":"Kessler RC, Andrews G, Colpe LJ, Hiripi E, Mroczek DK, Normand SL, et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol Med. 2002;32(6):959\u201376.","journal-title":"Psychol Med."},{"issue":"10","key":"6644_CR35","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727\u201336.","journal-title":"Qual Life Res."},{"issue":"2","key":"6644_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/crj.12198","volume":"10","author":"K Wortel","year":"2016","unstructured":"Altenburg Josje, Wortel K, De Graaff CS, Van Der Werf TS, Boersma WG. Validation of a visual analogue score (LRTI-VAS) in non-CF bronchiectasis. Clin Resp J. 2016;10(2):168\u201375.","journal-title":"Clin Resp J."},{"issue":"7","key":"6644_CR37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1136\/thx.54.7.581","volume":"54","author":"J Bestall","year":"1999","unstructured":"Bestall J, Paul E, Garrod R, Garnham R, Jones P, Wedzicha J. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581\u20136.","journal-title":"Thorax."},{"issue":"3","key":"6644_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1360-0443.2004.00995.x","volume":"100","author":"R West","year":"2005","unstructured":"West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005;100(3):299\u2013303.","journal-title":"Addiction."},{"issue":"5","key":"6644_CR39","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/ntr\/nts205","volume":"15","author":"KA Perkins","year":"2012","unstructured":"Perkins KA, Karelitz JL, Jao NC. Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence. Nic Tob Res. 2012;15(5):978\u201382.","journal-title":"Nic Tob Res."},{"issue":"7","key":"6644_CR40","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1056\/NEJMoa1808779","volume":"380","author":"P Hajek","year":"2019","unstructured":"Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, et al. A randomized trial of E-cigarettes versus nicotine-replacement therapy. NEJM. 2019;380(7):629\u201337.","journal-title":"NEJM."},{"issue":"2","key":"6644_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/096228029800700206","volume":"7","author":"J Stapleton","year":"1998","unstructured":"Stapleton J. Cigarette smoking prevalence, cessation and relapse. Stat Methods Med Res. 1998;7(2):187\u2013203.","journal-title":"Stat Methods Med Res."},{"key":"6644_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.addbeh.2016.07.019","volume":"64","author":"RJ Courtney","year":"2017","unstructured":"Courtney RJ, Clare P, Boland V, Martirea KA, Bonevski B, Hall W, et al. Predictors of retention in a randomised trial of smoking cessation in low-socioeconomic status Australian smokers. Addict Behav. 2017;64:13\u201320.","journal-title":"Addict Behav."},{"key":"6644_CR43","doi-asserted-by":"crossref","unstructured":"White IR, Horton NJ, Carpenter J, Pocock SJ. Strategy for intention to treat analysis in randomised trials with missing outcome data. BMJ. 2011;342:d40.","DOI":"10.1136\/bmj.d40"},{"key":"6644_CR44","unstructured":"Australian Government Department of Health. Therapeutic Goods (Standard for Nicotine Vaping Products) (TGO 110) Order 2021. https:\/\/www.legislation.gov.au\/Details\/F2021L00595. Accessed 4 Apr 2022."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06644-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-022-06644-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-022-06644-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T19:05:10Z","timestamp":1663182310000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-022-06644-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6644"],"URL":"https:\/\/doi.org\/10.1186\/s13063-022-06644-8","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]},"assertion":[{"value":"19 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial was approved by the University of New South Wales Human Research Ethics Committee (HC191025). This trial has been registered on the Australian New Zealand Clinical Trials Registry (ACTRN12621000076875). A clinical trial notification has been submitted to the Australian Therapeutic Goods Administration (Application ID: CT-2020-CTN00088-1 v5) for nicotine vaping products as they are not registered products listed on the Australian Register of Therapeutic Goods (ARTG). The trial will be conducted in accordance with the World Medical Association Declaration of Helsinki (1996), the NHMRC National Statement on Ethical Conduct in Human Research (2007, updated 2018), the principles of Good Clinical Practice (GCP), the Australian Code for the Responsible Conduct of Research (2007) and the current applicable regulatory requirements and any subsequent amendments of the appropriate regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No authors have received financial support from any companies for the submitted work. D.P. provides advice to the Australian Government Department of Health on funding decisions. C.M. was the founding chairman of the Australian Tobacco Harm Reduction Association a health promotion charity. He stepped down from the board in January 2021. Australian Tobacco Harm Reduction Association received funding from the vape industry to establish the charity. Funding was ceased in March 2019. He has not received any payments from electronic cigarette or tobacco companies. N. Z. is chair of an Expert Advisory Group for the Royal Australian College of General Practitioners smoking cessation guidelines. M.F. receives unrestricted research funding from Seqirus and Indivior.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"777"}}